A personalized mRNA vaccine for melanoma reduced the risk of the cancer returning in a phase III clinical trial, the ...

The drug giant restricted access to its Covid vaccine to protect its bottom line. Will history repeat itself now?

The personalized cancer vaccine being developed by Moderna and Merck has boosted hopes that mRNA technology could open up a ...

Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a ​new avenue of ...

Moderna’s mRNA vaccine combined with Merck’s immunotherapy Keytruda succeeded in a late-stage trial for skin cancer, the ...

Pharmaceutical partners Moderna and Merck announced on Wednesday that their novel mRNA-based vaccine—individually tailored to ...

The U.S. Food and Drug Administration approved Moderna, Novavax-Sanofi and Pfizer-BioNTech's updated COVID vaccines, the ...

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with ...

The U.S. Food and Drug Administration has approved on Thursday updated COVID-19 vaccines from Moderna Inc. MRNA, Pfizer Inc.

By Michael Erman and Julie Steenhuysen Aug 28 (Reuters) - Stephane Bancel, CEO of Moderna, was at a Lebanese restaurant ...